Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 593 entries
Sorted by: Best Match Show Resources per page
Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism.

Journal of thrombosis and thrombolysis

Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes RD, McBane RD, Moll S, Ansell J.
PMID: 26945859
J Thromb Thrombolysis. 2016 Apr;41(3):548. doi: 10.1007/s11239-016-1345-4.

No abstract available.

Cite
Streiff MB, Agnelli G, Connors JM, et al. Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis. 2016;41(3):548doi: 10.1007/s11239-016-1345-4.
Streiff, M. B., Agnelli, G., Connors, J. M., Crowther, M., Eichinger, S., Lopes, R. D., McBane, R. D., Moll, S., & Ansell, J. (2016). Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism. Journal of thrombosis and thrombolysis, 41(3), 548. https://doi.org/10.1007/s11239-016-1345-4
Streiff, Michael B, et al. "Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism." Journal of thrombosis and thrombolysis vol. 41,3 (2016): 548. doi: https://doi.org/10.1007/s11239-016-1345-4
Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes RD, McBane RD, Moll S, Ansell J. Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis. 2016 Apr;41(3):548. doi: 10.1007/s11239-016-1345-4. PMID: 26945859; PMCID: PMC4969909.
Copy Download .nbib Format: NLM
Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study.

Journal of thrombosis and thrombolysis

Schaffer A, Verdoia M, Cassetti E, Barbieri L, Perrone-Filardi P, Marino P, De Luca G.
PMID: 25800883
J Thromb Thrombolysis. 2015 Jul;40(1):69. doi: 10.1007/s11239-015-1206-6.

No abstract available.

Cite
Schaffer A, Verdoia M, Cassetti E, et al. Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study. J Thromb Thrombolysis. 2015;40(1):69doi: 10.1007/s11239-015-1206-6.
Schaffer, A., Verdoia, M., Cassetti, E., Barbieri, L., Perrone-Filardi, P., Marino, P., & De Luca, G. (2015). Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study. Journal of thrombosis and thrombolysis, 40(1), 69. https://doi.org/10.1007/s11239-015-1206-6
Schaffer, Alon, et al. "Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study." Journal of thrombosis and thrombolysis vol. 40,1 (2015): 69. doi: https://doi.org/10.1007/s11239-015-1206-6
Schaffer A, Verdoia M, Cassetti E, Barbieri L, Perrone-Filardi P, Marino P, De Luca G. Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study. J Thromb Thrombolysis. 2015 Jul;40(1):69. doi: 10.1007/s11239-015-1206-6. PMID: 25800883.
Copy Download .nbib Format: NLM
Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease.

Journal of thrombosis and thrombolysis

Latimer J, Batty JA, Neely RD, Kunadian V.
PMID: 27170165
J Thromb Thrombolysis. 2016 Oct;42(3):420. doi: 10.1007/s11239-016-1373-0.

No abstract available.

Cite
Latimer J, Batty JA, Neely RD, et al. Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease. J Thromb Thrombolysis. 2016;42(3):420doi: 10.1007/s11239-016-1373-0.
Latimer, J., Batty, J. A., Neely, R. D., & Kunadian, V. (2016). Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease. Journal of thrombosis and thrombolysis, 42(3), 420. https://doi.org/10.1007/s11239-016-1373-0
Latimer, James, et al. "Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease." Journal of thrombosis and thrombolysis vol. 42,3 (2016): 420. doi: https://doi.org/10.1007/s11239-016-1373-0
Latimer J, Batty JA, Neely RD, Kunadian V. Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease. J Thromb Thrombolysis. 2016 Oct;42(3):420. doi: 10.1007/s11239-016-1373-0. PMID: 27170165; PMCID: PMC6828237.
Copy Download .nbib Format: NLM
Pathobiology of Myocardial Necrosis.

Journal of thrombosis and thrombolysis

Waller BF.
PMID: 10639260
J Thromb Thrombolysis. 1997;4(2):177-184. doi: 10.1023/a:1008814111042.

No abstract available.

Cite
Waller BF. Pathobiology of Myocardial Necrosis. J Thromb Thrombolysis. 1997;4(2):177-184doi: 10.1023/a:1008814111042.
Waller, B. F. (1997). Pathobiology of Myocardial Necrosis. Journal of thrombosis and thrombolysis, 4(2), 177-184. https://doi.org/10.1023/a:1008814111042
Waller. "Pathobiology of Myocardial Necrosis." Journal of thrombosis and thrombolysis vol. 4,2 (1997): 177-184. doi: https://doi.org/10.1023/a:1008814111042
Waller BF. Pathobiology of Myocardial Necrosis. J Thromb Thrombolysis. 1997;4(2):177-184. doi: 10.1023/a:1008814111042. PMID: 10639260.
Copy Download .nbib Format: NLM
The Open Artery: Electrophysiologic Considerations.

Journal of thrombosis and thrombolysis

Haugh CJ, Homoud MK, Foote CB, Wang PJ, Estes III.
PMID: 10639266
J Thromb Thrombolysis. 1997;4(2):251-258. doi: 10.1023/a:1008847018311.

Prompt opening of the infarct-related artery reduces mortality and subsequent morbid events. Not all benefit of timely thrombolysis or angioplasty appears to be accounted for by myocardial preservation. A favorable modification of the electrophysiologic postinfarction milieu by a patent...

Cite
Haugh CJ, Homoud MK, Foote CB, et al. The Open Artery: Electrophysiologic Considerations. J Thromb Thrombolysis. 1997;4(2):251-258doi: 10.1023/a:1008847018311.
Haugh, C. J., Homoud, M. K., Foote, C. B., Wang, P. J., & Estes, I. I. I. (1997). The Open Artery: Electrophysiologic Considerations. Journal of thrombosis and thrombolysis, 4(2), 251-258. https://doi.org/10.1023/a:1008847018311
Haugh, et al. "The Open Artery: Electrophysiologic Considerations." Journal of thrombosis and thrombolysis vol. 4,2 (1997): 251-258. doi: https://doi.org/10.1023/a:1008847018311
Haugh CJ, Homoud MK, Foote CB, Wang PJ, Estes III. The Open Artery: Electrophysiologic Considerations. J Thromb Thrombolysis. 1997;4(2):251-258. doi: 10.1023/a:1008847018311. PMID: 10639266.
Copy Download .nbib Format: NLM
Coronary Artery Patency and Survival in Clinical Trials.

Journal of thrombosis and thrombolysis

Ellis CJ, French JK, White HD.
PMID: 10639265
J Thromb Thrombolysis. 1997;4(2):239-250. doi: 10.1023/a:1008894901473.

Central to many of the major advances seen in the treatment of acute myocardial infarction over the last 15 years has been the concept that reperfusion by thrombolytic therapy, by producing early patency of an infarct-related artery, salvages myocardium...

Cite
Ellis CJ, French JK, White HD. Coronary Artery Patency and Survival in Clinical Trials. J Thromb Thrombolysis. 1997;4(2):239-250doi: 10.1023/a:1008894901473.
Ellis, C. J., French, J. K., & White, H. D. (1997). Coronary Artery Patency and Survival in Clinical Trials. Journal of thrombosis and thrombolysis, 4(2), 239-250. https://doi.org/10.1023/a:1008894901473
Ellis, et al. "Coronary Artery Patency and Survival in Clinical Trials." Journal of thrombosis and thrombolysis vol. 4,2 (1997): 239-250. doi: https://doi.org/10.1023/a:1008894901473
Ellis CJ, French JK, White HD. Coronary Artery Patency and Survival in Clinical Trials. J Thromb Thrombolysis. 1997;4(2):239-250. doi: 10.1023/a:1008894901473. PMID: 10639265.
Copy Download .nbib Format: NLM
Primary Angioplasty Is the Ideal Treatment for Acute Myocardial Infarction.

Journal of thrombosis and thrombolysis

Lambrew CT.
PMID: 10639636
J Thromb Thrombolysis. 1997;4(3):329-330. doi: 10.1023/a:1008884930046.

No abstract available.

Cite
Lambrew CT. Primary Angioplasty Is the Ideal Treatment for Acute Myocardial Infarction. J Thromb Thrombolysis. 1997;4(3):329-330doi: 10.1023/a:1008884930046.
Lambrew, C. T. (1997). Primary Angioplasty Is the Ideal Treatment for Acute Myocardial Infarction. Journal of thrombosis and thrombolysis, 4(3), 329-330. https://doi.org/10.1023/a:1008884930046
Lambrew. "Primary Angioplasty Is the Ideal Treatment for Acute Myocardial Infarction." Journal of thrombosis and thrombolysis vol. 4,3 (1997): 329-330. doi: https://doi.org/10.1023/a:1008884930046
Lambrew CT. Primary Angioplasty Is the Ideal Treatment for Acute Myocardial Infarction. J Thromb Thrombolysis. 1997;4(3):329-330. doi: 10.1023/a:1008884930046. PMID: 10639636.
Copy Download .nbib Format: NLM
Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense.

Journal of thrombosis and thrombolysis

Brieger D, Topol E.
PMID: 10639635
J Thromb Thrombolysis. 1997;4(3):325-327. doi: 10.1023/a:1008832913207.

Two large multicenter clinical trials comparing heparin with hirudin in the management of patients with acute coronary syndromes have recently been completed. Direct thrombin inhibition was reported to result in only a modest reduction in the incidence of primary...

Cite
Brieger D, Topol E. Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense. J Thromb Thrombolysis. 1997;4(3):325-327doi: 10.1023/a:1008832913207.
Brieger, D., & Topol, E. (1997). Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense. Journal of thrombosis and thrombolysis, 4(3), 325-327. https://doi.org/10.1023/a:1008832913207
Brieger, and Topol. "Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense." Journal of thrombosis and thrombolysis vol. 4,3 (1997): 325-327. doi: https://doi.org/10.1023/a:1008832913207
Brieger D, Topol E. Hirudin in Acute Coronary Syndromes: When Cents Override Good Sense. J Thromb Thrombolysis. 1997;4(3):325-327. doi: 10.1023/a:1008832913207. PMID: 10639635.
Copy Download .nbib Format: NLM
Thrombophilia in Patients with Hypertriglyceridemia.

Journal of thrombosis and thrombolysis

Chan P, Huang TY, Shieh SM, Lin TS, Tsai CW.
PMID: 10639647
J Thromb Thrombolysis. 1997;4(3):425-429. doi: 10.1023/a:1008857618659.

Objectives: To investigate a possible relationship between hypertriglyceridemia and the coagulation system, a Cardiovascular Risk Factor Two-township Study was conducted in Taiwan. Design: A case-control study. This longitudinal, prospective study focused on the evolution of cardiovascular disease risk factors...

Cite
Chan P, Huang TY, Shieh SM, et al. Thrombophilia in Patients with Hypertriglyceridemia. J Thromb Thrombolysis. 1997;4(3):425-429doi: 10.1023/a:1008857618659.
Chan, P., Huang, T. Y., Shieh, S. M., Lin, T. S., & Tsai, C. W. (1997). Thrombophilia in Patients with Hypertriglyceridemia. Journal of thrombosis and thrombolysis, 4(3), 425-429. https://doi.org/10.1023/a:1008857618659
Chan, et al. "Thrombophilia in Patients with Hypertriglyceridemia." Journal of thrombosis and thrombolysis vol. 4,3 (1997): 425-429. doi: https://doi.org/10.1023/a:1008857618659
Chan P, Huang TY, Shieh SM, Lin TS, Tsai CW. Thrombophilia in Patients with Hypertriglyceridemia. J Thromb Thrombolysis. 1997;4(3):425-429. doi: 10.1023/a:1008857618659. PMID: 10639647.
Copy Download .nbib Format: NLM
Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art.

Journal of thrombosis and thrombolysis

Tan HC, Harrington RA, Tcheng JE.
PMID: 10639648
J Thromb Thrombolysis. 1997;4(3):431-439. doi: 10.1023/a:1008809702729.

Platelets have been shown to play an important role in the pathogenesis of atherosclerosis, acute coronary syndromes, and ischemic complications after percutaneous coronary intervention. Fibrinogen binding via platelet surface glycoprotein (GP) IIb/IIIa receptors constitutes the "final pathway" in platelet...

Cite
Tan HC, Harrington RA, Tcheng JE. Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art. J Thromb Thrombolysis. 1997;4(3):431-439doi: 10.1023/a:1008809702729.
Tan, H. C., Harrington, R. A., & Tcheng, J. E. (1997). Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art. Journal of thrombosis and thrombolysis, 4(3), 431-439. https://doi.org/10.1023/a:1008809702729
Tan, et al. "Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art." Journal of thrombosis and thrombolysis vol. 4,3 (1997): 431-439. doi: https://doi.org/10.1023/a:1008809702729
Tan HC, Harrington RA, Tcheng JE. Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art. J Thromb Thrombolysis. 1997;4(3):431-439. doi: 10.1023/a:1008809702729. PMID: 10639648.
Copy Download .nbib Format: NLM
Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning.

Journal of thrombosis and thrombolysis

Elliott GT.
PMID: 10613986
J Thromb Thrombolysis. 1996;3(3):225-237. doi: 10.1007/BF00181665.

Myocardial tissue appears to possess an endogenous protective mechanism whereby brief ischemic periods precondition cells to better withstand both reversible and irreversible injury associated with prolonged subsequent ischemic events. Protection develops within minutes of transient ischemia, dissipates within 1-2...

Cite
Elliott GT. Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning. J Thromb Thrombolysis. 1996;3(3):225-237doi: 10.1007/BF00181665.
Elliott, G. T. (1996). Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning. Journal of thrombosis and thrombolysis, 3(3), 225-237. https://doi.org/10.1007/BF00181665
Elliott. "Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning." Journal of thrombosis and thrombolysis vol. 3,3 (1996): 225-237. doi: https://doi.org/10.1007/BF00181665
Elliott GT. Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning. J Thromb Thrombolysis. 1996;3(3):225-237. doi: 10.1007/BF00181665. PMID: 10613986.
Copy Download .nbib Format: NLM
Acute Ethanol Does Not Protect Against Ischemic/Reperfusion Injury in Rabbit Myocardium.

Journal of thrombosis and thrombolysis

Bellows SD, Hale SL, Kloner RA.
PMID: 10613980
J Thromb Thrombolysis. 1996;3(3):181-184. doi: 10.1007/BF00181659.

Moderate use of alcohol has shown protective effects in coronary artery disease, while excessive use has been associated with cardiomyopathy and hypertension. Since alcohol is a vasodilator, we postulated that it might have protective effects when administered acutely in...

Cite
Bellows SD, Hale SL, Kloner RA. Acute Ethanol Does Not Protect Against Ischemic/Reperfusion Injury in Rabbit Myocardium. J Thromb Thrombolysis. 1996;3(3):181-184doi: 10.1007/BF00181659.
Bellows, S. D., Hale, S. L., & Kloner, R. A. (1996). Acute Ethanol Does Not Protect Against Ischemic/Reperfusion Injury in Rabbit Myocardium. Journal of thrombosis and thrombolysis, 3(3), 181-184. https://doi.org/10.1007/BF00181659
Bellows, et al. "Acute Ethanol Does Not Protect Against Ischemic/Reperfusion Injury in Rabbit Myocardium." Journal of thrombosis and thrombolysis vol. 3,3 (1996): 181-184. doi: https://doi.org/10.1007/BF00181659
Bellows SD, Hale SL, Kloner RA. Acute Ethanol Does Not Protect Against Ischemic/Reperfusion Injury in Rabbit Myocardium. J Thromb Thrombolysis. 1996;3(3):181-184. doi: 10.1007/BF00181659. PMID: 10613980.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 593 entries